A new more detailed stratification of low responders to ovarian stimulation From a poor ovarian response to a low prognosis concept

Wednesday, June 1, 2016

Authors:
Poseidon Group (Patient-Oriented Strategies Encompassing Individualized Oocyte Number), Carlo Alviggi, M.D., Ph.D., Claus Y.…

Read More

Age independent from ovarian reserve status is the main prognostic factor in natural cycle in vitro fertilization

Tuesday, April 5, 2016

Authors:
Iñaki González-Foruria, M.D., Juana Peñarrubia, M.D., Aina Borràs, M.D., Dolors Manau, M.D., Gemma Casals, M.D., Sara Peralta, M.D., Montserrat Creus, M.D., Janisse Ferreri, M.D., Ester Vidal, Ph.D., Francisco Carmona, M.D., Juan Balasch, M.D., Francisco Fàbregues, M.D.…

Read More

Does the addition of growth hormone to the in vitro fertilization intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders A randomized controlled trial

Tuesday, March 1, 2016
The addition of growth hormone to the antagonist protocol in poor-responder women undergoing in vitro fertilization/intracytoplasmic sperm injection cycles resulted in better cycle outcomes but did not significantly affect pregnancy rates.

Read More

Diminished ovarian reserve in the United States assisted reproductive technology population Diagnostic trends among 181536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System

Tuesday, September 1, 2015
Diminished ovarian reserve (DOR) assignment increased 7% among all Society for Assisted Reproductive Technology Clinic Outcomes Reporting System cycles from 2004 to 2011, despite minimal increase in patient age at cycle start. The ability of DOR assignment to predict poor ovarian response worsened.

Read More

Poor ovarian response in women undergoing in vitro fertilization is associated with altered microRNA expression in cumulus cells

Monday, June 1, 2015
We discuss how poor response to controlled ovarian hyperstimulation in in vitro fertilization is associated with altered microRNA expression in cumulus cells.

Read More

Long gonadotropin releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing IVF a randomized controlled trial

Tuesday, December 31, 2013
The long gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist regimens offer suitable choices for women with poor ovarian response undergoing IVF. The short GnRH agonist regimen is the least effective for poor responders.

Read More

Using the ovarian sensitivity index to define poor normal and high response after COH in the long GnRH agonist protocol Suggestions for a new principle to solve an old problem

Thursday, October 31, 2013
Poor, normal, and high ovarian responses were defined with the use of the ovarian sensitivity index, the ratio between oocyte yield and total dose of FSH, in a large unselected IVF cohort.

Read More

Translate »